{"id":"boric-acid","rwe":[{"pmid":"41904359","year":"2026","title":"Retraction Note: Boric Acid Inhibits RANKL-Stimulated Osteoclastogenesis In Vitro and Attenuates LPS-Induced Bone Loss In Vivo.","finding":"","journal":"Biological trace element research","studyType":"Clinical Study"},{"pmid":"41898588","year":"2026","title":"Synthesis of Antioxidative p-Terphenyl Dimers via Boronic Acid-Mediated C-C Coupling.","finding":"","journal":"International journal of molecular sciences","studyType":"Clinical Study"},{"pmid":"41898364","year":"2026","title":"Combined Antineoplastic Effects of Metformin, Boric Acid and Resveratrol in SKOV3 Ovarian Cancer Cells.","finding":"","journal":"Biomedicines","studyType":"Clinical Study"},{"pmid":"41897464","year":"2026","title":"Boric Acid Mitigates Alcohol-Induced Renal Podocyte Injury, Apoptosis, and Oxidative Stress in HBV Transgenic Mice.","finding":"","journal":"Antioxidants (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41897129","year":"2026","title":"Effects of Boric Acid and Chlorhexidine as Cavity Disinfectants on Microleakage and Microshear Bond Strength in Primary Teeth.","finding":"","journal":"Children (Basel, Switzerland)","studyType":"Clinical Study"}],"_fda":{"id":"2fae9a9c-1b17-5954-e063-6394a90ac2ed","set_id":"02b3d683-05b0-4075-bbf9-e6d97c61765c","openfda":{"unii":["R57ZHV85D4","MOR84MUD8E","JK0MS9P8YL","33X04XA5AT","24WE03BX2T"],"route":["TOPICAL"],"spl_id":["2fae9a9c-1b17-5954-e063-6394a90ac2ed"],"brand_name":["Medicated Foaming Feminine"],"spl_set_id":["02b3d683-05b0-4075-bbf9-e6d97c61765c"],"package_ndc":["83004-015-01"],"product_ndc":["83004-015"],"generic_name":["LACTIC ACID, BORIC ACID, CHLORHEXIDINE GLUCONATE, CNIDIUM MONNIERI FRUIT, LEVOMENOL"],"product_type":["HUMAN OTC DRUG"],"substance_name":["BORIC ACID","CHLORHEXIDINE GLUCONATE","CNIDIUM MONNIERI FRUIT OIL","LACTIC ACID","LEVOMENOL"],"manufacturer_name":["Rida LLC"],"is_original_packager":[true]},"purpose":[""],"version":"1","warnings":["Warnings ● For external use only. ● Do not use: ○ On broken or punctured wounds. ○ On animal bites. ○ On serious burns. ● When using this product: ○ Avoid contact with eyes. If contact occurs, rinse thoroughly with water. ○ Do not apply large amounts to the body. ● Stop use and ask a doctor if: ○ Irritation or redness develops. ○ Condition worsens or does not improve within 7 days."],"effective_time":"20250306","active_ingredient":["Active Ingredient Purpose ● Lactic Acid 0.5%: Maintains natural pH levels, fostering a healthy environment to prevent irritation and infections. ● Boric Acid 0.5%: Restores and stabilizes acidic pH levels, effectively preventing yeast infections. ● Chlorhexidine Digluconate 1%: Offers potent antibacterial protection, reducing the risk of bacterial infections without disrupting the vaginal flora. ● Cnidium Monnieri Fruit Extract 0.5%: Provides anti-inflammatory properties, soothing the skin and reducing any potential irritation. ● Bisabolol 0.3%: Calms and soothes the skin, reducing redness and providing a gentle, comforting effect upon application."],"inactive_ingredient":["Inactive ingredients Water (Aqua), Glycerin, Cocamidopropyl Betaine, Sodium Lauryl Glucose Carboxylate, Lauryl Glucoside, Xanthan Gum, Sodium Benzoate Citric Acid, Allantoin, Panthenol, Aloe Barbadensis Leaf Juice, Tocopherol (Vitamin E), Ethylhexylglycerin"],"indications_and_usage":["Uses ● Antimicrobial action: Effectively targets and eliminates harmful bacteria to maintain natural balance. ● UTI Defense: Actively helps to prevent urinary tract infections. ● Odor Control: Neutralizes odors, leaving you feeling fresh and clean."],"spl_unclassified_section":["Other Information ● Lot number and expiration date: See packaging for details. ● Keep out of reach of children. If swallowed, call a poison control center right away. ● Store at room temperature. Keep the bottle tightly closed. Avoid direct sunlight and excessive heat to maintain product integrity."],"dosage_and_administration":["Directions ● Wet the area: Begin by splashing water on the external vaginal area or take this step while in the shower or bath to ensure the area is moist. ● Apply the wash: Pump a small amount of the foam onto your hand. The foam should be rich and airy. Typically, two pumps are sufficient. ● Gentle Cleansing: Gently apply foam to the delicate areas. Use your hand to spread the foam, covering the entire area with gentle, circular motions. Avoid using sponges or washcloths, as they can be too abrasive. ● Rinse thoroughly: After cleansing, rinse thoroughly with warm water. Ensure all traces of the wash are removed to avoid irritation. ● Pat dry: Gently pat the area with a clean towel. Avoid rubbing, as this may cause irritation. It's important to ensure the area is completely dry before dressing to prevent moisture buildup, which can lead to irritation or infections."],"spl_product_data_elements":["Medicated Foaming Feminine LACTIC ACID, BORIC ACID, CHLORHEXIDINE GLUCONATE, CNIDIUM MONNIERI FRUIT, LEVOMENOL WATER COCAMIDOPROPYL BETAINE SODIUM LAURYL GLYCOL CARBOXYLATE LAURYL GLUCOSIDE XANTHAN GUM SODIUM BENZOATE CITRIC ACID ALLANTOIN PANTHENOL ALOE VERA LEAF TOCOPHEROL ETHYLHEXYLGLYCERIN GLYCERIN LACTIC ACID LACTIC ACID BORIC ACID BORIC ACID CHLORHEXIDINE GLUCONATE CHLORHEXIDINE CNIDIUM MONNIERI FRUIT OIL CNIDIUM MONNIERI FRUIT OIL LEVOMENOL BISABOLOL"],"keep_out_of_reach_of_children":[""],"package_label_principal_display_panel":["Product label image description"]},"tags":[{"label":"boric acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"S02AA03","category":"atc"},{"label":"Topical","category":"route"},{"label":"Ophthalmic","category":"route"},{"label":"Cutaneous","category":"route"},{"label":"Emulsion","category":"form"},{"label":"Gel","category":"form"},{"label":"Liquid","category":"form"},{"label":"Ointment","category":"form"},{"label":"Active","category":"status"},{"label":"Antiseptic preparation","category":"indication"},{"label":"Insecticides","category":"pharmacology"},{"label":"Pesticides","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"116 reports"},{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"111 reports"},{"date":"","signal":"JOINT SWELLING","source":"FDA FAERS","actionTaken":"109 reports"},{"date":"","signal":"PAIN IN EXTREMITY","source":"FDA FAERS","actionTaken":"109 reports"},{"date":"","signal":"INFECTION","source":"FDA FAERS","actionTaken":"107 reports"},{"date":"","signal":"MUSCULOSKELETAL STIFFNESS","source":"FDA FAERS","actionTaken":"107 reports"},{"date":"","signal":"HEPATOTOXICITY","source":"FDA FAERS","actionTaken":"106 reports"},{"date":"","signal":"CONDITION AGGRAVATED","source":"FDA FAERS","actionTaken":"105 reports"},{"date":"","signal":"MUSCULOSKELETAL PAIN","source":"FDA FAERS","actionTaken":"105 reports"},{"date":"","signal":"NEOPLASM MALIGNANT","source":"FDA FAERS","actionTaken":"105 reports"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=BORIC ACID","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:55:29.597148+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:55:35.423935+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BORIC ACID","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:55:35.989787+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:55:28.336669+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:55:28.336701+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-19T23:55:38.349874+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL42403/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:55:37.573766+00:00"}},"allNames":"boracic acid","offLabel":[],"synonyms":["boric acid","boracic acid","trihydroxyborane","orthoboric acid","boron oxide hydroxide"],"timeline":[],"brandName":"Boracic Acid","ecosystem":[{"indication":"Antiseptic preparation","otherDrugs":[{"name":"chloroxylenol","slug":"chloroxylenol","company":""},{"name":"ethanol","slug":"ethanol","company":"B Braun"},{"name":"hydrogen peroxide","slug":"hydrogen-peroxide","company":""},{"name":"isopropanol","slug":"isopropanol","company":""}],"globalPrevalence":null}],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","drugClass":"boric acid","explanation":"","oneSentence":"","technicalDetail":"Boracic Acid exerts its antiseptic effects by forming a complex with the cell membrane of microorganisms, ultimately leading to the disruption of membrane function and the death of the microorganism."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3035","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=BORIC%20ACID","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BORIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:05:25.816244","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:55:39.646938+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"chloramphenicol","drugSlug":"chloramphenicol","fdaApproval":"1950-12-08","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"nitrofurazone","drugSlug":"nitrofurazone","fdaApproval":"1945-10-04","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"clioquinol","drugSlug":"clioquinol","fdaApproval":"","relationship":"same-class"},{"drugName":"hydrogen peroxide","drugSlug":"hydrogen-peroxide","fdaApproval":"","patentExpiry":"Jul 4, 2035","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"neomycin","drugSlug":"neomycin","fdaApproval":"1957-03-26","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tetracycline","drugSlug":"tetracycline","fdaApproval":"1953-11-19","genericCount":34,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"chlorhexidine","drugSlug":"chlorhexidine","fdaApproval":"1976-09-17","patentExpiry":"Oct 2, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"acetic acid","drugSlug":"acetic-acid","fdaApproval":"1960-05-17","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"Polymyxin B","drugSlug":"polymyxin-b","fdaApproval":"1957-03-26","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"rifamycin","drugSlug":"rifamycin","fdaApproval":"2018-11-16","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"miconazole","drugSlug":"miconazole","fdaApproval":"1974-01-08","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"gentamicin","drugSlug":"gentamicin","fdaApproval":"1970-06-19","genericCount":36,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ciprofloxacin","drugSlug":"ciprofloxacin","fdaApproval":"1987-10-22","patentExpiry":"Nov 27, 2038","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ofloxacin","drugSlug":"ofloxacin","fdaApproval":"1990-12-28","genericCount":20,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fosfomycin","drugSlug":"fosfomycin","fdaApproval":"1996-12-19","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cefmenoxime","drugSlug":"cefmenoxime","fdaApproval":"1987-12-30","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"boric acid","indications":{"approved":[{"name":"Antiseptic preparation","source":"DrugCentral","snomedId":261276004,"regulator":"FDA","eligibility":"all ages, for most forms of skin irritations, rashes, non-poisonous insect bites, minor cuts, scrapes, burns, sunburn, chafed, chapped, cracked or wind burned skin and lips"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"chloramphenicol","brandName":"chloramphenicol","genericName":"chloramphenicol","approvalYear":"1950","relationship":"same-class"},{"drugId":"nitrofurazone","brandName":"nitrofurazone","genericName":"nitrofurazone","approvalYear":"1945","relationship":"same-class"},{"drugId":"clioquinol","brandName":"clioquinol","genericName":"clioquinol","approvalYear":"","relationship":"same-class"},{"drugId":"hydrogen-peroxide","brandName":"hydrogen peroxide","genericName":"hydrogen peroxide","approvalYear":"","relationship":"same-class"},{"drugId":"neomycin","brandName":"neomycin","genericName":"neomycin","approvalYear":"1957","relationship":"same-class"},{"drugId":"tetracycline","brandName":"tetracycline","genericName":"tetracycline","approvalYear":"1953","relationship":"same-class"},{"drugId":"chlorhexidine","brandName":"chlorhexidine","genericName":"chlorhexidine","approvalYear":"1976","relationship":"same-class"},{"drugId":"acetic-acid","brandName":"acetic acid","genericName":"acetic acid","approvalYear":"1960","relationship":"same-class"},{"drugId":"polymyxin-b","brandName":"Polymyxin B","genericName":"Polymyxin B","approvalYear":"1957","relationship":"same-class"},{"drugId":"rifamycin","brandName":"rifamycin","genericName":"rifamycin","approvalYear":"2018","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02943525","phase":"NA","title":"Vaginal Packing After Laparoscopic Sacrocolpopexy","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2016-11-14","conditions":["Vaginal Packing Following Laparoscopic Sacrocolpopexy","Pelvic Organ Prolapse"],"enrollment":253,"completionDate":"2023-07-02"},{"nctId":"NCT07109869","phase":"PHASE3","title":"Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis","status":"RECRUITING","sponsor":"pH-D Feminine Health LLC","startDate":"2025-08-08","conditions":["Vulvovaginal Candidiases","Vulvovaginal Candidiasis, Genital","Vulvovaginal Candidiasis (VVC)"],"enrollment":400,"completionDate":"2026-06"},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":["Atropine Bioequivalence"],"enrollment":46,"completionDate":"2024-05-22"},{"nctId":"NCT07295210","phase":"NA","title":"Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":["Otomycosis"],"enrollment":60,"completionDate":"2025-12-01"},{"nctId":"NCT06731725","phase":"NA","title":"Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye","status":"COMPLETED","sponsor":"i+Med S.Coop.","startDate":"2021-02-17","conditions":["Dry Eye","Dry Eye Syndrome (DES)"],"enrollment":20,"completionDate":"2022-02-23"},{"nctId":"NCT04829344","phase":"PHASE3","title":"A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution","status":"COMPLETED","sponsor":"American Genomics, LLC","startDate":"2021-03-30","conditions":["Anesthesia, Local"],"enrollment":120,"completionDate":"2021-05-10"},{"nctId":"NCT06516757","phase":"NA","title":"A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.","status":"COMPLETED","sponsor":"Love Wellness","startDate":"2024-04-05","conditions":["Vaginal Health","Bacterial Vaginosis"],"enrollment":40,"completionDate":"2024-07-05"},{"nctId":"NCT04930107","phase":"EARLY_PHASE1","title":"Vulvovaginal Candidiasis in Canadian Females","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2021-12-07","conditions":["Candidiasis, Vulvovaginal"],"enrollment":105,"completionDate":"2026-04-30"},{"nctId":"NCT04376268","phase":"PHASE4","title":"Comparison of the Efficacy of Boric Acid Mouthwashes in Different Concentrations","status":"UNKNOWN","sponsor":"Yuzuncu Yil University","startDate":"2019-01-15","conditions":["Impacted Third Molar Tooth"],"enrollment":80,"completionDate":"2023-12-15"},{"nctId":"NCT04938908","phase":"PHASE2","title":"Probiotic in Dry Eye Syndromes","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2021-07-01","conditions":["Dry Eye Syndrome"],"enrollment":40,"completionDate":"2022-07-30"},{"nctId":"NCT05564832","phase":"EARLY_PHASE1","title":"Pharmacological Treatment of Presbyopia","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-08-01","conditions":["Near Vision"],"enrollment":75,"completionDate":"2023-01-01"},{"nctId":"NCT04513652","phase":"PHASE3","title":"A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution","status":"COMPLETED","sponsor":"American Genomics, LLC","startDate":"2020-09-03","conditions":["Anesthesia, Local"],"enrollment":120,"completionDate":"2020-12-17"},{"nctId":"NCT04824261","phase":"NA","title":"Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-06-01","conditions":["Otomycosis"],"enrollment":100,"completionDate":"2023-06-01"},{"nctId":"NCT03765957","phase":"EARLY_PHASE1","title":"Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells","status":"UNKNOWN","sponsor":"Central South University","startDate":"2019-02-20","conditions":["Psoriasis"],"enrollment":12,"completionDate":"2021-06-01"},{"nctId":"NCT02004067","phase":"PHASE4","title":"Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2013-01","conditions":["Primary Sjogren Syndrome","Secondary Sjogren Syndrome","Aqueous Deficient Dry Eye Disease","Evaporative Dry Eye Disease"],"enrollment":100,"completionDate":"2016-08"},{"nctId":"NCT04208555","phase":"NA","title":"Comparison of Boric Acid vs. Terconazole in Treatment of RVVC","status":"UNKNOWN","sponsor":"Hatem AbuHashim","startDate":"2020-01-15","conditions":["Vulvovaginal Candidiasis"],"enrollment":76,"completionDate":"2021-05-31"},{"nctId":"NCT02860845","phase":"PHASE4","title":"Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections","status":"COMPLETED","sponsor":"Laboratorios Ordesa","startDate":"2016-07-12","conditions":["Candidiasis","Vaginosis, Bacterial"],"enrollment":48,"completionDate":"2017-11-30"},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":["Dry Eye Syndrome"],"enrollment":326,"completionDate":"2018-12-16"},{"nctId":"NCT01541891","phase":"PHASE2","title":"Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2011-10","conditions":["Dry Eye Syndrome"],"enrollment":30,"completionDate":"2012-05"},{"nctId":"NCT03140111","phase":"NA","title":"LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients","status":"UNKNOWN","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2017-10-16","conditions":["Dry Eye Syndromes","Primary Sjögren Syndrome"],"enrollment":12,"completionDate":"2018-03-30"},{"nctId":"NCT00799214","phase":"PHASE2,PHASE3","title":"BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2014-04","conditions":["Bacterial Vaginosis"],"enrollment":13,"completionDate":"2016-02"},{"nctId":"NCT02903108","phase":"PHASE2,PHASE3","title":"Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis","status":"COMPLETED","sponsor":"Government Dental College and Research Institute, Bangalore","startDate":"2015-05","conditions":["Chronic Periodontitis"],"enrollment":39,"completionDate":"2015-10"},{"nctId":"NCT02059655","phase":"PHASE4","title":"Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)","status":"COMPLETED","sponsor":"Cardiff University","startDate":"2014-11","conditions":["Graves' Ophthalmopathy"],"enrollment":31,"completionDate":"2016-03"},{"nctId":"NCT02738515","phase":"PHASE2,PHASE3","title":"Boric Acid in Degree 2 Furcation Defect","status":"COMPLETED","sponsor":"Government Dental College and Research Institute, Bangalore","startDate":"2015-07","conditions":["Chronic Periodontitis With Mandibular Degree 2 Furcation Defects"],"enrollment":48,"completionDate":"2016-02"},{"nctId":"NCT02517957","phase":"PHASE2","title":"Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2015-08","conditions":["Eczema"],"enrollment":342,"completionDate":""},{"nctId":"NCT01547221","phase":"NA","title":"Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients","status":"COMPLETED","sponsor":"Khon Kaen Hospital","startDate":"2012-03","conditions":["Otomycosis"],"enrollment":120,"completionDate":"2015-04"},{"nctId":"NCT02087215","phase":"PHASE1","title":"Effect of Local Application of Boron on Diabetic Foot Ulcers","status":"UNKNOWN","sponsor":"Bezmialem Vakif University","startDate":"2014-01","conditions":["Diabetic Foot Ulcer"],"enrollment":100,"completionDate":"2015-03"},{"nctId":"NCT00874887","phase":"PHASE4","title":"A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-03","conditions":["Anti-biotic Resistance"],"enrollment":66,"completionDate":"2009-10"},{"nctId":"NCT01384851","phase":"NA","title":"Efficacy of the Chronic Application of Tear Formulations","status":"UNKNOWN","sponsor":"Glasgow Caledonian University","startDate":"2011-07","conditions":["Dry Eye"],"enrollment":38,"completionDate":"2011-11"},{"nctId":"NCT00353561","phase":"PHASE3","title":"Diabetes Mellitus and Vulvovaginal Candidiasis","status":"COMPLETED","sponsor":"Indian Council of Medical Research","startDate":"2004-06","conditions":["Diabetes Mellitus","Vulvovaginal Candidiasis"],"enrollment":100,"completionDate":"2006-04"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Emulsion, Gel, Liquid, Ointment","formulations":[{"form":"EMULSION","route":"TOPICAL","productName":"GYNOX-SOFT"},{"form":"GEL","route":"CUTANEOUS","productName":"ICEKING Skin Expert Anti-onychomycosis Gel"},{"form":"LIQUID","route":"OPHTHALMIC","productName":"See Clean-One Eye Drops"},{"form":"LIQUID","route":"ORAL","productName":"Gynetox"},{"form":"OINTMENT","route":"TOPICAL","productName":"Sha-lem"}]},"crossReferences":{"NUI":"N0000146538","MMSL":"4294","NDDF":"003185","UNII":"R57ZHV85D4","VUID":"4018204","CHEBI":"CHEBI:33118","VANDF":"4018204","RXNORM":"1700","UMLSCUI":"C0006020","chemblId":"CHEMBL42403","ChEMBL_ID":"CHEMBL42403","KEGG_DRUG":"D01089","DRUGBANK_ID":"DB11326","PDB_CHEM_ID":" BO3","PUBCHEM_CID":"7628","SNOMEDCT_US":"21611007","MESH_SUPPLEMENTAL_RECORD_UI":"C032688"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3530,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"S02AA03","allCodes":["S02AA03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 28","pmid":"41904359","title":"Retraction Note: Boric Acid Inhibits RANKL-Stimulated Osteoclastogenesis In Vitro and Attenuates LPS-Induced Bone Loss In Vivo.","journal":"Biological trace element research"},{"date":"2026 Mar 17","pmid":"41898588","title":"Synthesis of Antioxidative p-Terphenyl Dimers via Boronic Acid-Mediated C-C Coupling.","journal":"International journal of molecular sciences"},{"date":"2026 Mar 20","pmid":"41898364","title":"Combined Antineoplastic Effects of Metformin, Boric Acid and Resveratrol in SKOV3 Ovarian Cancer Cells.","journal":"Biomedicines"},{"date":"2026 Mar 3","pmid":"41897464","title":"Boric Acid Mitigates Alcohol-Induced Renal Podocyte Injury, Apoptosis, and Oxidative Stress in HBV Transgenic Mice.","journal":"Antioxidants (Basel, Switzerland)"},{"date":"2026 Mar 18","pmid":"41897129","title":"Effects of Boric Acid and Chlorhexidine as Cavity Disinfectants on Microleakage and Microshear Bond Strength in Primary Teeth.","journal":"Children (Basel, Switzerland)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:55:39.646938+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}